Healthcare provider profile · identity verified

Mark Alan Mckeague, MD

Internal Medicine · YORK, PA · NPI 1346269693

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	480	123
Amlodipine Besylate	Amlodipine Besylate	278	78
Losartan Potassium	Losartan Potassium	276	75
Lisinopril	Lisinopril	252	60
Levothyroxine Sodium	Levothyroxine Sodium	238	51
Omeprazole	Omeprazole	219	55
Hydrochlorothiazide	Hydrochlorothiazide	174	46
Rosuvastatin Calcium	Rosuvastatin Calcium	159	52
Gabapentin	Gabapentin	155	42
Metoprolol Succinate	Metoprolol Succinate	145	35
Sertraline Hcl	Sertraline Hcl	142	38
Eliquis	Apixaban	131	26
Simvastatin	Simvastatin	131	30
Metformin Hcl	Metformin Hcl	125	35
Tamsulosin Hcl	Tamsulosin Hcl	119	31
Furosemide	Furosemide	112	37
Escitalopram Oxalate	Escitalopram Oxalate	101	30
Carvedilol	Carvedilol	85	23
Metoprolol Tartrate	Metoprolol Tartrate	85	22
Pantoprazole Sodium	Pantoprazole Sodium	84	30
Clopidogrel	Clopidogrel Bisulfate	81	23
Clonazepam	Clonazepam	77	suppressed
Oxycodone Hcl	Oxycodone Hcl	71	19
Lorazepam	Lorazepam	70	20
Famotidine	Famotidine	68	16
Albuterol Sulfate Hfa	Albuterol Sulfate	67	23
Trazodone Hcl	Trazodone Hcl	62	17
Venlafaxine Hcl Er	Venlafaxine Hcl	61	suppressed
Prednisone	Prednisone	59	36
Jardiance	Empagliflozin	57	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	17
Celecoxib	Celecoxib	53	14
Ozempic	Semaglutide	53	15
Allopurinol	Allopurinol	52	13
Ezetimibe	Ezetimibe	51	suppressed
Glipizide Er	Glipizide	48	14
Pravastatin Sodium	Pravastatin Sodium	48	13
Fluticasone Propionate	Fluticasone Propionate	47	17
Meloxicam	Meloxicam	47	15
Tramadol Hcl	Tramadol Hcl	47	14
Alprazolam	Alprazolam	46	suppressed
Chlorthalidone	Chlorthalidone	46	11
Metformin Hcl Er	Metformin Hcl	45	18
Finasteride	Finasteride	43	suppressed
Potassium Chloride	Potassium Chloride	42	13
Spironolactone	Spironolactone	42	13
Duloxetine Hcl	Duloxetine Hcl	41	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	12
Nifedipine Er	Nifedipine	41	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Bupropion Xl	Bupropion Hcl	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Montelukast Sodium	Montelukast Sodium	39	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Synthroid	Levothyroxine Sodium	37	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Novolog Flexpen	Insulin Aspart	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	14
Triamcinolone Acetonide	Triamcinolone Acetonide	34	17
Atenolol	Atenolol	33	suppressed
Glipizide	Glipizide	32	suppressed
Meclizine Hcl	Meclizine Hcl	30	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Pregabalin	Pregabalin	29	11
Morphine Sulfate Er	Morphine Sulfate	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Bumetanide	Bumetanide	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Torsemide	Torsemide	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Estradiol	Estradiol	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Nitroglycerin	Nitroglycerin	20	14
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Irbesartan	Irbesartan	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	13
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Sucralfate	Sucralfate	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Naproxen	Naproxen	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Oxycontin	Oxycodone Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Cephalexin	Cephalexin	14	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Ethosuximide	Ethosuximide	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Ramipril	Ramipril	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Baclofen	Baclofen	11	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Ciclopirox	Ciclopirox Olamine	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error